Financial Daily from THE HINDU group of publications
Sunday, Jun 02, 2002
Markets - Rights Issues
KOPRAN has approached shareholders with a rights issue of equity in the ratio of one share for every two shares held.
The rights issue has been priced at Rs 40 per share, and the company hopes to raise Rs 28.60 crore.
Following the rights issue, Kopran's issued share capital will increase 50 per cent to Rs 85.30 crore.
Kopran is engaged primarily in the manufacture and sale of pharmaceutical formulations (drugs in a ready-to-consume form such as tablets). The company's revenue is derived largely from cardiovascular and respiratory formulations.
Shareholders may consider avoiding subscription to the rights offer for the following reasons:
Over the last two years, Kopran's loans have been about 1-1.21 times the equity shareholders' funds.
In an attempt to reduce the proportion of loans in the company's capital structure, about 70 per cent of the money from the rights issue will be used to pay existing long-term debt.
If the promoters do not subscribe to the rights issue, their holding will drop from 49.31 per cent to 44 per cent.
More so, when one considers the guarantees given by Kopran for KDL Biotech's borrowings. On the positive side, Kopran sold a leading cardiovascular brand, Aten, to Zydus Cadila last year. The deal has led to an inflow of Rs 75 crore in fiscal 2002, and another Rs 20 crore will follow in the years to come.
While the deal takes away a leading brand, it reduces the pressure on Kopran's financial situation. The share price in the stock market has been around Rs 40. But an overview of the situation suggests that it may not be prudent to increase exposure to Kopran.
The company has significant hurdles to clear, and more exposure at this stage appears unduly risky for a long-term investor.
Subscribing for the rights offer at Rs 40, about 5 times Kopran's annualised earnings per share (EPS) in 2001-02, may be avoided.
Issue highlights: The offer ratio is one share for every two held. The issue price is Rs 40 per share. The issue closes on June 7. The lead manager is KJMC Global Market.
Send this article to Friends by E-Mail
Stories in this Section
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2002, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line